Cite
Prognostic Factors in Patients With Stemi Undergoing Primary PCI in the Clopidogrel Era: Role of Dual Antiplatelet Therapy at Admission and the Smoking Paradox on Long-Term Outcome
MLA
Ciccarelli, Giovanni, et al. “Prognostic Factors in Patients With Stemi Undergoing Primary PCI in the Clopidogrel Era: Role of Dual Antiplatelet Therapy at Admission and the Smoking Paradox on Long-Term Outcome.” Journal of Interventional Cardiology, vol. 30, no. 1, Dec. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....fec930a12a3d4215dc3bb6b79b7ebaa2&authtype=sso&custid=ns315887.
APA
Ciccarelli, G., Barbato, E., Golino, M., Cimmino, G., Bartunek, J., Di Serafino, L., Di Girolamo, D., De Bruyne, B., Wijns, W., & Golino, P. (2016). Prognostic Factors in Patients With Stemi Undergoing Primary PCI in the Clopidogrel Era: Role of Dual Antiplatelet Therapy at Admission and the Smoking Paradox on Long-Term Outcome. Journal of Interventional Cardiology, 30(1).
Chicago
Ciccarelli, Giovanni, Emanuele Barbato, Marco Golino, Giovanni Cimmino, Jozef Bartunek, Luigi Di Serafino, Domenico Di Girolamo, Bernard De Bruyne, William Wijns, and Paolo Golino. 2016. “Prognostic Factors in Patients With Stemi Undergoing Primary PCI in the Clopidogrel Era: Role of Dual Antiplatelet Therapy at Admission and the Smoking Paradox on Long-Term Outcome.” Journal of Interventional Cardiology 30 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....fec930a12a3d4215dc3bb6b79b7ebaa2&authtype=sso&custid=ns315887.